A-Tech Labs
TIRZEPATIDE – A-Tech Labs
TIRZEPATIDE – A-Tech Labs is a new drug that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in the management of type 2 diabetes and is currently the subject of studies aimed at evaluating its potential benefits in weight management.
$98.28
Tirzepatide works by activating both GIP and GLP-1 receptors, which stimulates insulin secretion, reduces glucagon levels and slows gastric emptying. This dual action improves glycemic control and reduces appetite, thus promoting weight loss.